These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7757975

  • 1. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
    Lutchman M, Rouleau GA.
    Cancer Res; 1995 Jun 01; 55(11):2270-4. PubMed ID: 7757975
    [Abstract] [Full Text] [Related]

  • 2. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP, Pulst SM.
    Oncogene; 1996 Jul 04; 13(1):73-84. PubMed ID: 8700556
    [Abstract] [Full Text] [Related]

  • 3. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ, McClatchey AI, Jacks T.
    Cell Growth Differ; 1998 Apr 04; 9(4):287-96. PubMed ID: 9563848
    [Abstract] [Full Text] [Related]

  • 4. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
    Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B.
    Nature; 1993 Jun 10; 363(6429):515-21. PubMed ID: 8379998
    [Abstract] [Full Text] [Related]

  • 5. [Neurofibromatosis type 2 (NF2)].
    Araki N, Takeshima H, Saya H.
    Gan To Kagaku Ryoho; 1997 Sep 10; 24(11):1427-31. PubMed ID: 9309136
    [Abstract] [Full Text] [Related]

  • 6. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH.
    Oncogene; 1997 Nov 13; 15(20):2505-9. PubMed ID: 9395247
    [Abstract] [Full Text] [Related]

  • 7. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
    Huynh DP, Tran TM, Nechiporuk T, Pulst SM.
    Cell Growth Differ; 1996 Nov 13; 7(11):1551-61. PubMed ID: 8930405
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.
    Kanai Y, Tsuda H, Oda T, Sakamoto M, Hirohashi S.
    Jpn J Clin Oncol; 1995 Feb 13; 25(1):1-4. PubMed ID: 7877257
    [Abstract] [Full Text] [Related]

  • 9. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR, Huynh DP, Morcos PA, Coulsell ER, Robinson NG, Tamanoi F, Pulst SM.
    Nat Genet; 1998 Apr 13; 18(4):354-9. PubMed ID: 9537418
    [Abstract] [Full Text] [Related]

  • 10. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H, Izawa I, Lee PS, Safdar N, Levin VA, Saya H.
    Oncogene; 1994 Aug 13; 9(8):2135-44. PubMed ID: 8035998
    [Abstract] [Full Text] [Related]

  • 11. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI, Haipek CA, Gutmann DH.
    Oncogene; 2004 Jan 15; 23(2):580-7. PubMed ID: 14724586
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R, Waha A, Vogel Y, Lenartz D, Schramm J, Wiestler OD, von Deimling A.
    Lab Invest; 1997 Dec 15; 77(6):601-6. PubMed ID: 9426397
    [Abstract] [Full Text] [Related]

  • 13. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
    Johnson KC, Kissil JL, Fry JL, Jacks T.
    Oncogene; 2002 Sep 05; 21(39):5990-7. PubMed ID: 12203111
    [Abstract] [Full Text] [Related]

  • 14. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B, Ballhausen WG, Kressel M.
    Eur J Cell Biol; 1997 Jan 05; 72(1):46-53. PubMed ID: 9013725
    [Abstract] [Full Text] [Related]

  • 15. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR.
    Nat Genet; 1994 Feb 05; 6(2):185-92. PubMed ID: 8162073
    [Abstract] [Full Text] [Related]

  • 16. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H.
    Oncogene; 1998 Aug 20; 17(7):801-10. PubMed ID: 9779996
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of colony formation of NIH 3T3 cells by the expression of the small molecular weight heat shock protein HSP27: involvement of its phosphorylation and aggregation at the C-terminal region.
    Arata S, Hamaguchi S, Nose K.
    J Cell Physiol; 1997 Jan 20; 170(1):19-26. PubMed ID: 9012781
    [Abstract] [Full Text] [Related]

  • 18. Effects of Nf2 missense mutations on schwannomin interactions.
    Scoles DR, Chen M, Pulst SM.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):366-74. PubMed ID: 11779178
    [Abstract] [Full Text] [Related]

  • 19. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
    Lee IK, Kim KS, Kim H, Lee JY, Ryu CH, Chun HJ, Lee KU, Lim Y, Kim YH, Huh PW, Lee KH, Han SI, Jun TY, Rha HK.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):774-83. PubMed ID: 15541357
    [Abstract] [Full Text] [Related]

  • 20. NF2: the wizardry of merlin.
    Xiao GH, Chernoff J, Testa JR.
    Genes Chromosomes Cancer; 2003 Dec 17; 38(4):389-99. PubMed ID: 14566860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.